v3.23.3
Realized Gains or Losses and Net Unrealized Appreciation or Depreciation (Tables)
12 Months Ended
Sep. 30, 2023
Investment Company [Abstract]  
Schedule of Aggregate Net Realized Gains
During the year ended September 30, 2023, the Company recorded an aggregate net realized loss of $33.2 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
SIO2 Medical Products Inc.$(13.9)
Convergeone Holdings Inc.(6.0)
Foreign currency forward contracts(5.8)
Aden & Anais Merger Sub Inc.(5.2)
Radiology Partners Inc.(4.2)
Carvana Co. (2.8)
Impel Neuropharma Inc.(2.3)
ASP Unifrax Holdings Inc.(2.1)
WP CPP Holdings LLC(1.3)
Global Medical Response Inc.(1.0)
Athenex Inc.6.5 
Tersera Therapeutics LLC5.2 
CorEvitas Group Holdings LP4.0 
Other, net (4.3)
Total, net
$(33.2)
During the year ended September 30, 2022, the Company recorded an aggregate net realized gain of $17.2 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$13.7 
OmniSYS Acquisition Corporation2.2 
First Star Speir Aviation Limited1.9 
TigerConnect Inc.1.8 
WP CPP Holdings, LLC(1.7)
Other, net(0.7)
Total, net
$17.2 
During the year ended September 30, 2021, the Company recorded an aggregate net realized gain of $26.4 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
PLATO Learning Inc.$7.8 
Keypath Education Holdings, LLC6.8 
L Squared Capital Partners LLC3.4 
LTI Holdings, Inc.2.6 
BX Commercial Mortgage Trust 2020-VIVA2.6 
California Pizza Kitchen Inc.(1.8)
Refac Optical Group(1.3)
Other, net6.3 
Total, net
$26.4